The loss of FBXW7 has been shown to be also strongly associated with carcinogenesis, tumor metastasis, and resistance to chemo-, radiation-, and immuno-therapies, leading to poorer outcomes [2,26]. The gene discussed is FBXW7; the disease is neoplasm.